Use of low titer <scp>O</scp> whole blood in infants and young children undergoing cardiac surgery with cardiopulmonary bypass
The use of LTOWB appears to be safe in <2 years old undergoing cardiac surgery and may reduce re-explorations for severe bleeding. Large trials are needed to determine the efficacy and safety of LTOWB in this population with severe bleeding.
Authors
- Michael D. Evans (ORCID: https://orcid.org/0000-0001-7449-3993)
- N. T. Joyner
- Philip Charles Spinella (ORCID: https://orcid.org/0000-0003-1721-0541)
- Sameh M. Said (ORCID: https://orcid.org/0000-0003-2193-0314)
- Julie Welbig
- Claudia S. Cohn (ORCID: https://orcid.org/0000-0001-9847-0470)
- Gregory J. Beilman (ORCID: https://orcid.org/0000-0001-5036-3027)
- Massimo Griselli
- Nicole D. Zantek (ORCID: https://orcid.org/0000-0001-5776-6400)
- Marie E. Steiner (ORCID: https://orcid.org/0000-0003-4169-1920)
- Kayla Fahey‐Arndt
- Martina Richtsfeld
Institutions
- Princess Nourah bint Abdulrahman University (SA)
- University of Minnesota (US)
- Fairview Health Services (US)
- Westchester Medical Center (US)
- University of Pittsburgh (US)
- Medtronic (United States) (US)
- Maria Fareri Children's Hospital (US)
- Southern California Clinical and Translational Science Institute (US)
- University of Minnesota Children's Hospital (US)
Publication Details
- Journal
- Transfusion
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1111/trf.18014
- Citations
- 2
- Primary Topic
- Cardiac Arrest and Resuscitation
- Type
- article
- Field-Weighted Citation Impact
- 1.38
Funders
- Children's Hospital of Philadelphia
- University of Minnesota
- National Institutes of Health
- National Center for Advancing Translational Sciences